GlaxoSmithKline, Pharmaceuticals industry, Business, University of Oxford, Education, UK news, Cancer research, Medical research, Science Business | The Guardian
Collaboration over at least three years aims to help understand how pre-cancerous cells developBusiness live – latest updatesGSK has said it will spend £50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop. Continue reading…
Collaboration over at least three years aims to help understand how pre-cancerous cells develop
GSK has said it will spend £50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.
The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop.
